Columnist Jen Cueva has gotten more adept at listening to her body and making adjustments to manage her PH and leave room for joy.

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).